News
Since COVID-19 onset, admissions for MI are down, mortality rates are up
August 13, 2020
Acute MI admissions fell but mortality rose with the onset of COVID-19 pandemic.
News
COVID-19/heart connection: What hospitalists need to know
August 13, 2020
Be selective in ordering cardiac biomarker tests for COVID-19 patients, cardiologist advises.
News
‘Doubling down’ on hydroxychloroquine QT prolongation in COVID-19
August 12, 2020
Patients had progressively longer QT intervals with hydroxychloroquine plus azithromycin, but also frequently received other drugs that had QT-prolonging effects, in a new study.
News
Rapid cycle pediatric simulation exercises promise improved readiness
August 11, 2020
A nonjudgmental but firm critique of weaknesses during urgent care simulation exercises fosters readiness.
News
Hypertension often goes undertreated in patients with a history of stroke
August 10, 2020
Uncontrolled hypertension is common, even among those who have survived a stroke.
News
PVR reassessed as predictor of heart failure
August 7, 2020
A reconsideration of the accepted benchmark for pulmonary vascular hypertension as a predictor of heart failure may be warranted.
News
HM20 Virtual Product Theater: Aug. 12
August 6, 2020
Hear from Dr. Michael Oleksyk, clinical assistant professor at Florida State University, Pensacola, to learn more about venous thromboembolism prophylaxis, as well as treatment options for patients with deep vein thrombosis and/or pulmonary embolism.
News
All NSAIDs raise post-MI risk but some are safer than others: Next chapter
August 5, 2020
A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen for some of the drugs are real.
News
ACC panel defines, advises on heart failure with ‘recovered’ EF
August 5, 2020
An American College of Cardiology expert panel has issued a definition of heart failure with recovered ejection fraction and recommendations for diagnosis and treatment.
News
Early palliative care fails to improve QOL in advanced heart failure
August 3, 2020
“My first reaction is disappointment. We had hoped to see the ENABLE program, which had been successful in cancer, translate to the heart failure setting.”